U.S. biotech stocks win back investors in big July run

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to U.S. biotech stocks win back investors in big July run

Baird Incrementally Positive on Biogen (BIIB) Nusinersen Data; PT to $284

August 1, 2016 3:16 PM EDT

Baird analyst Brian Skorney bumped his price target on Biogen (NASDAQ: BIIB) to $284.00 (from $268.00) but lefts his Neutral rating, saying they are incrementally positive on nusinersen interim Phase 3 results.

Skorney commented, "Results are in, earlier than expected, and nusinersen appears to... More